A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
SARASOTA, Fla., June 15, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...
Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., May 17, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., May 11, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture...
Aggressive go-to-market sales, partnerships, and marketing strategy to bring INVOcell, fertility care that is accessible, inclusive, and affordable to the more than 90% of couples in need of fertility treatment that currently go without care.SARASOTA, Fla., May 10,...
Current Senior Advisor at McKinsey & Co. with strong expertise in global marketing and brand buildingSARASOTA, Fla., April 26, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal...
- RESOLVE is a non-profit action-based, infertility and family building organization who want to see increased access to all family building options- It's estimated that nearly 90% of couples in need of infertility treatment go without careSARASOTA, Fla., April 22,...
- Approximately one in eight couples are affected by infertility in the United StatesSARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal...
SARASOTA, Fla., April 12, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world's only in vivo Intravaginal Culture System,...
Company to Host Conference Call on March 30 at 4:30pm ET (Details Below)SARASOTA, Fla., March 30, 2021 -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers...
SARASOTA, Fla., March 29, 2021 -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcell®, an effective and affordable treatment for patients diagnosed with...